24/7 Market News Snapshot 19 Jul 2024 – Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (NASDAQ: CYTO)

July 19, 2024 8:42

Press Release

DENVER, Colo., 19 July, 2024 (247marketnews.com) – (Nasdaq:CYTO) are discussed in this article.
Altamira Therapeutics Ltd. (CYTO) has experienced a notable uptick in stock performance, rising by 24.85% and peaking at $1.670 from an opening of $1.362, signaling a positive shift from the previous close at $1.340. The robust trading volume of 3.5 million underscores growing investor optimism, with technical analysis hinting at a continuation of this upward trajectory and potential for further price appreciation. This surge presents opportunities for investors to strategically enter the market and monitor key resistance levels for potential gains, reflecting heightened market interest and strong growth prospects for Altamira Therapeutics Ltd.

On another front, Altamira Therapeutics Ltd. has unveiled a groundbreaking study showcasing significant advancements in the treatment of abdominal aortic aneurysms (AAA). The research, featuring a pioneering approach utilizing SOD2 mRNA delivered through peptide-based nanoparticles known as SemaPhore™, demonstrated remarkable efficacy in addressing AAA in animal models. Results revealed a reduction in aorta dilation, delayed rupture, and increased survival rates in AAA mice, marking a substantial leap forward in combating this critical medical condition.

The study, conducted by a reputable research group, showcases the potential of Altamira’s RNA delivery technology to revolutionize therapeutic interventions for aortic aneurysms, offering a beacon of hope for patients and healthcare professionals. This milestone underscores Altamira Therapeutics Ltd.’s dedication to driving scientific progress and impactful innovations in healthcare. Stay tuned for further updates on Altamira’s groundbreaking research efforts shaping the future of medical advancements.

For additional insights on this pivotal study, refer to the official news source for comprehensive details.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.